Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
223.37
-7.98 (-3.45%)
At close: Nov 13, 2026, 4:00 PM EST
220.28
-3.09 (-1.38%)
After-hours: Nov 13, 2026, 5:32 PM EST
Moderna Stock Forecast
Stock Price Forecast
According to 23 analysts polled by S&P Global, Moderna stock has a consensus rating of "Hold" and an average price target of $158.47. The average 1-year stock price forecast is 29.05% lower than the current stock price, while the lowest is $45 (-79.85%) and the highest is $305 (+36.54%).
Price Target: $158.47 (-29.05%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Moderna stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 4 | 4 | 3 | 3 |
| Buy | 1 | 2 | 1 | 1 | 1 | 1 |
| Hold | 17 | 16 | 17 | 15 | 15 | 16 |
| Sell | 3 | 2 | 1 | 1 | 2 | 1 |
| Strong Sell | 1 | 1 | 0 | 2 | 2 | 2 |
| Total | 24 | 23 | 23 | 23 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Hold Maintains $260 | Hold | Maintains | $260 | +16.40% | Nov 13, 2026 |
| Citi | Citi | Sell Maintains $60 → $80 | Sell | Maintains | $60 → $80 | -64.18% | Nov 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $305 | Buy | Reiterates | $305 | +36.54% | Nov 13, 2026 |
| Evercore ISI | Evercore ISI | Hold Maintains $80 | Hold | Maintains | $80 | -64.18% | Nov 13, 2026 |
| UBS | UBS | Hold Reiterates $150 → $225 | Hold | Reiterates | $150 → $225 | +0.73% | Nov 9, 2026 |
Financial Forecast
Revenue This Year
2.41B
from 1.94B
Increased by 24.04%
Revenue Next Year
2.67B
from 2.41B
Increased by 10.79%
EPS This Year
-7.27
from -7.26
EPS Next Year
-4.08
from -7.27
EPS and Forward PE are based on non-GAAP adjusted numbers.